# EDGAR Filing Document

**Accession Number:** 0001479026
**File Stem:** 0000940400-25-004974
**Filing Date:** 2025-10
**Character Count:** 17891
**Document Hash:** 4398355beb176d379a104dae845fa3cd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-25-004974.hdr.sgml**: 20251021

**ACCESSION NUMBER**: 0000940400-25-004974

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250831

**FILED AS OF DATE**: 20251021

**DATE AS OF CHANGE**: 20251021

**PERIOD START**: 20250831

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Goldman Sachs ETF Trust
- **CENTRAL INDEX KEY:** 0001479026

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23013
- **FILM NUMBER:** 251407596

**BUSINESS ADDRESS:**
- **STREET 1:** 200 WEST STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10282-2198
- **BUSINESS PHONE:** (312) 655-4400

**MAIL ADDRESS:**
- **STREET 1:** 200 WEST STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10282-2198

## Series and Classes Contracts Data

### Goldman Sachs Future Health Care Equity ETF (Series ID: S000072296)

| Class ID   | Class Name                                  | Ticker Symbol   |
|:---|:---|:---|
| C000228400 | Goldman Sachs Future Health Care Equity ETF | GDOC            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Goldman Sachs ETF Trust

- **b. Investment Company Act file number:** 811-23013

- **c. CIK number of Registrant:** 0001479026

- **d. LEI of Registrant:** 549300VEZF7K2ES5WL82

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 200 West Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10282

  - **Telephone number:** 312-655-4400

**Item A.2. Information about the Series.**

- **a. Name of Series:** Goldman Sachs Future Health Care Equity ETF

- **b. EDGAR series identifier (if any):** S000072296

- **c. LEI of Series:** 5493005ZE64A38F67X14

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-08-31

- **b. Date as of which information is reported:** 2025-08-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $20314112.74

**Total Liabilities:** $5784.56

**Net Assets:** $20308328.18

**Cash Not Reported:** $451.82

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000228400 | 2.35%                | -3.01%               | 5.18%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-494405.83              | $942874.83                                 |
| Month 2  | $-182759.13              | $-418391.21                                |
| Month 3  | $-855443.75              | $1851652.23                                |

### Schedule of Portfolio Investments

| Name                                                     | Title                                                    | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Insmed Inc                                               | Insmed Inc                                               | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |      1473 | NS      | $200475.30    | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMarin Pharmaceutical Inc                              | BioMarin Pharmaceutical Inc                              | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |      9935 | NS      | $578912.45    | 2.85%             |  |  |  | No            |                  1 | On Loan: No      |
| BioNTech SE                                              | BioNTech SE                                              | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |       956 | NS      | $95600.00     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Mettler-Toledo International I                           | Mettler-Toledo International Inc                         | CUSIP: 592688105<br>LEI: 5493000BD5GJNUDIUG10 | Long             | EC               | CORP              | US        |       295 | NS      | $383806.80    | 1.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical Inc                            | Ultragenyx Pharmaceutical Inc                            | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |      3490 | NS      | $104560.40    | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc                               | Neurocrine Biosciences Inc                               | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |      4067 | NS      | $567753.20    | 2.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                                                | Argenx SE                                                | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |       844 | NS      | $601096.80    | 2.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                                               | Natera Inc                                               | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       929 | NS      | $156304.25    | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Roivant Sciences Ltd                                     | Roivant Sciences Ltd                                     | CUSIP: 000000000<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | US        |     17426 | NS      | $207892.18    | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Apogee Therapeutics Inc                                  | Apogee Therapeutics Inc                                  | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3944 | NS      | $143443.28    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc                             | Thermo Fisher Scientific Inc                             | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |      1520 | NS      | $748934.40    | 3.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                                      | Abbott Laboratories                                      | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |      9880 | NS      | $1310680.80   | 6.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Madrigal Pharmaceuticals Inc                             | Madrigal Pharmaceuticals Inc                             | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |       515 | NS      | $225492.75    | 1.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp                                   | Boston Scientific Corp                                   | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |     16640 | NS      | $1755520.00   | 8.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc                              | Alnylam Pharmaceuticals Inc                              | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |      1508 | NS      | $673337.08    | 3.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Cencora Inc                                              | Cencora Inc                                              | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |      1391 | NS      | $405629.51    | 2.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Hoya Corp                                                | Hoya Corp                                                | CUSIP: 000000000<br>LEI: 353800X4VR3BHEUCJB42 | Long             | EC               | CORP              | JP        |      4556 | NS      | $597330.15    | 2.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Sartorius Stedim Biotech                                 | Sartorius Stedim Biotech                                 | CUSIP: 000000000<br>LEI: 52990006IVXY7GCSSR39 | Long             | EC               | CORP              | FR        |      1259 | NS      | $257743.27    | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Align Technology Inc                                     | Align Technology Inc                                     | CUSIP: 016255101<br>LEI: 549300N5YSE0U3LCP840 | Long             | EC               | CORP              | US        |      1320 | NS      | $187387.20    | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines Inc                                 | Revolution Medicines Inc                                 | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |      2610 | NS      | $99101.70     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Veeva Systems Inc                                        | Veeva Systems Inc                                        | CUSIP: 922475108<br>LEI: 549300YZEXPDB92M2F02 | Long             | EC               | CORP              | US        |      1914 | NS      | $515248.80    | 2.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Goldman Sachs Financial Square Treasury Obligations Fund | Goldman Sachs Financial Square Treasury Obligations Fund | CUSIP: 38141W323<br>LEI: 549300C0TCI4VJPGCS21 | Long             | STIV             | RF                | US        |    302347 | NS      | $302346.55    | 1.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Xenon Pharmaceuticals Inc                                | Xenon Pharmaceuticals Inc                                | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |      4046 | NS      | $156620.66    | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| MoonLake Immunotherapeutics                              | MoonLake Immunotherapeutics                              | CUSIP: 61559X104<br>LEI: N/A                  | Long             | EC               | CORP              | CH        |      3408 | NS      | $189996.00    | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                                          | AstraZeneca PLC                                          | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |      5829 | NS      | $928494.46    | 4.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Dexcom Inc                                               | Dexcom Inc                                               | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |      7217 | NS      | $543728.78    | 2.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Agilent Technologies Inc                                 | Agilent Technologies Inc                                 | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |      5078 | NS      | $638101.48    | 3.14%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                                               | AbbVie Inc                                               | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |      5370 | NS      | $1129848.00   | 5.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Cooper Cos Inc/The                                       | Cooper Cos Inc/The                                       | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |      4323 | NS      | $291348.59    | 1.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Kyowa Kirin Co Ltd                                       | Kyowa Kirin Co Ltd                                       | CUSIP: 000000000<br>LEI: 529900TBXKVTQGYA3582 | Long             | EC               | CORP              | JP        |     13251 | NS      | $229687.01    | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Insulet Corp                                             | Insulet Corp                                             | CUSIP: 45784P101<br>LEI: 549300TZTYD2PYN92D43 | Long             | EC               | CORP              | US        |      2931 | NS      | $996188.28    | 4.91%             |  |  |  | No            |                  1 | On Loan: No      |
| West Pharmaceutical Services I                           | West Pharmaceutical Services Inc                         | CUSIP: 955306105<br>LEI: 5493007NKRGM1RJQ1P16 | Long             | EC               | CORP              | US        |       578 | NS      | $142737.10    | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Lonza Group AG                                           | Lonza Group AG                                           | CUSIP: 000000000<br>LEI: 549300EFW4H2TCZ71055 | Long             | EC               | CORP              | CH        |       964 | NS      | $684047.31    | 3.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                                             | Danaher Corp                                             | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |      1743 | NS      | $358744.26    | 1.77%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                                   | UnitedHealth Group Inc                                   | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |       783 | NS      | $242628.21    | 1.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                                           | Eli Lilly & Co                                           | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |      2528 | NS      | $1851962.24   | 9.12%             |  |  |  | No            |                  1 | On Loan: No      |
| iRhythm Technologies Inc                                 | iRhythm Technologies Inc                                 | CUSIP: 450056106<br>LEI: 549300FJI72RJGDQS384 | Long             | EC               | CORP              | US        |      1829 | NS      | $310893.42    | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                                         | Novo Nordisk A/S                                         | CUSIP: 000000000<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |      9283 | NS      | $522284.75    | 2.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical Inc                                   | Intuitive Surgical Inc                                   | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |      2027 | NS      | $959368.97    | 4.72%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-10-21

**Name of Applicant:** Goldman Sachs ETF Trust

**Signature:** Peter Fortner

**Name of Signer:** Peter Fortner

**Title:** Vice President Assistant Treasurer